Percutaneous Neurolysis with Continuous Radiofrequency Energy for the Treatment of Symptomatic Sacroiliac Joints: S tudy of Clinical Safety and Efficacy

Visit for more related articles at Neurological Science Journal

Abstract

To prove safety and efficacy of percutaneous neurolysis with continuous radiofrequency energy for the treatment of symptomatic sacroiliac joints in a series of consecutive patients.

Materials and methods: During the last 2 years, 15 patients suffering from low back pain due to degenerative disorder of the sacroiliac joint underwent percutaneous neurolysis with continuous radiofrequency energy. Under extended local sterility and fluoroscopy 4 cannulas were placed along the sacral foramina and at the L5- S1 level and neurolysis session was performed post motor and sensory evaluation test. NVS pain scores prior and post therapy were compared using Paired Samples t-Test and Wilcoxon Signed Rank Test.

Results: Mean pain score prior to any therapy was 8.05±1.449 NVS units. Mean pain score post therapy was 2.37 ± 2.715, 2.42 ± 2.754, 2.70 ± 2.928 and 3.55 ± 2.837 NVS units at 1, 6, 12, 24 months. The comparison of the patients’ selfreported outcomes concerning pain reduction and mobility improvement prior and post therapy is statistically significant (p<0.001). No complication was noted.

Select your language of interest to view the total content in your interested language

Viewing options

Flyer image

Share This Article